Directory
>
Mb William Sheridan Fracp Facp
Mb William Sheridan Fracp Facp
Chief Development Officer | BioCryst Pharmaceuticals, Inc.
Santa Barbara, California, United States
Mb William Sheridan Fracp Facp
Summary
Mb William Sheridan Fracp Facp is a distinguished Chief Development Officer at BioCryst Pharmaceuticals, specializing in the biotechnology sector with a strong focus on rare diseases. With over three decades of experience in clinical development and drug strategy, he has played pivotal roles in launching several innovative therapies. His tenure at Amgen spanned 14 years, where he led significant medical affairs initiatives across the US and Europe. A graduate of the University of Melbourne, he is a board-certified Fellow of the Royal Australasian College of Physicians, showcasing his commitment to medical excellence. Notably, he has been a principal investigator in groundbreaking studies published in prestigious journals like The Lancet. Outside of his corporate responsibilities, he is passionate about mentoring the next generation of leaders in the biotechnology field.
Mb William Sheridan Fracp Facp
Work Experience
Chief Development Officer at
BioCryst Pharmaceuticals, Inc.
September 2022 - Present
Chief Medical Officer at
BioCryst Pharmaceuticals, Inc.
July 2008 - September 2022
Sole Proprietor at
Wps Biotech Consulting
November 2007 - June 2008
Vice President, North American Medical Affairs at
Amgen
July 2007 - November 2007
Vice President, International Medical Affairs at
Amgen Europe
February 2005 - June 2007
Vice President, Global Health Economics and Outcomes Research at
Amgen
January 2004 - February 2005
Vice President, US Medical Affairs at
Amgen
January 2002 - December 2003
Vice President, Product Development at
Amgen
March 2000 - December 2001
Senior Director, Product Development at
Amgen
July 1998 - February 2000
Director, Clinical Hematology at
Amgen
March 1993 - June 1998
Head, Bone Marrow Transplant Service at
The Royal Melbourne Hospital
January 1991 - March 1993
Assistant Medical Oncologist at
The Royal Melbourne Hospital
August 1986 - March 1993
Research Fellow at
Emory University School Of Medicine
February 1985 - August 1986
Locum Consultant Physician at
Prince Henrys Hospital And Royal Hobart Hospital
February 1984 - January 1985
Hematology - Medical Oncology Registrar (Fellow) at
Prince Henrys Hospital
February 1982 - January 1984
Internal Medicine Registrar (Fellow) at
Prince Henrys Hospital
February 1981 - January 1983
Internal Medicine Resident at
Prince Henrys Hospital
February 1979 - January 1981
Intern at
The Royal Melbourne Hospital
February 1978 - January 1979
Mb William Sheridan Fracp Facp
Education
The University of Melbourne, Mb Bs
January 1972 - January 1977
The University of Melbourne, Mb Bs
January 1972 - January 1977
Frequently Asked Questions about Mb William Sheridan Fracp Facp
What is Mb William Sheridan Fracp Facp email address?
Mb William Sheridan Fracp Facp's primary email address is *********@biocryst.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mb William Sheridan Fracp Facp work for?
Mb William Sheridan Fracp Facp is a Chief Development Officer at BioCryst Pharmaceuticals, Inc., a company specializing in Commercial physical research.
Where Mb William Sheridan Fracp Facp graduated from?
Mb William Sheridan Fracp Facp holds a degree in Medicine from The University of Melbourne.
How can I directly contact Mb William Sheridan Fracp Facp?
To contact Mb William Sheridan Fracp Facp directly, you can use the email address *********@biocryst.com. Complete contact information is available upon registration with Muraena.
Is Mb William Sheridan Fracp Facp an immigrant?
Yes, Mb William Sheridan Fracp Facp is an immigrant and currently based in United States
Who is Mb William Sheridan Fracp Facp?
Mb William Sheridan Fracp Facp is a distinguished Chief Development Officer at BioCryst Pharmaceuticals, specializing in the biotechnology sector with a strong focus on rare diseases. With over three decades of experience in clinical development and drug strategy, he has played pivotal roles in launching several innovative therapies. His tenure at Amgen spanned 14 years, where he led significant medical affairs initiatives across the US and Europe. A graduate of the University of Melbourne, he is a board-certified Fellow of the Royal Australasian College of Physicians, showcasing his commitment to medical excellence. Notably, he has been a principal investigator in groundbreaking studies published in prestigious journals like The Lancet. Outside of his corporate responsibilities, he is passionate about mentoring the next generation of leaders in the biotechnology field.
Mb`s contact details
*********@biocryst.com
Colleagues
Chief People Officer
Executive Director Product Development,CMC
Senior Vice President Medicinal chemistry
VP, Global Commercial Supply Chain
Chief of Staff - Research, Development, Medical Affairs
Vice President, HR Business Partner
Executive Director, Commercial Financial Planning & Analysis
Executive Director, Digital Communications
Vice President, Biometrics
Sr. Vice President Global Supply Chain